BRPI0412716A - antagonistas de receptor muscarìnico de acetilcolina - Google Patents

antagonistas de receptor muscarìnico de acetilcolina

Info

Publication number
BRPI0412716A
BRPI0412716A BRPI0412716-1A BRPI0412716A BRPI0412716A BR PI0412716 A BRPI0412716 A BR PI0412716A BR PI0412716 A BRPI0412716 A BR PI0412716A BR PI0412716 A BRPI0412716 A BR PI0412716A
Authority
BR
Brazil
Prior art keywords
receptor antagonists
acetylcholine receptor
muscarinic acetylcholine
muscarinic
acetilcoline
Prior art date
Application number
BRPI0412716-1A
Other languages
English (en)
Inventor
Kristen E Belmonte
Jakob Busch-Petersen
Dramane Laine
Michael R Palovich
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BRPI0412716A publication Critical patent/BRPI0412716A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"ANTAGONISTAS DE RECEPTOR MUSCARìNICO DE ACETILCOLINA". São providos Antagonistas de Receptor Muscarínico de Acetilcolina e métodos para uso dos mesmos.
BRPI0412716-1A 2003-07-17 2004-07-16 antagonistas de receptor muscarìnico de acetilcolina BRPI0412716A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48798103P 2003-07-17 2003-07-17
PCT/US2004/022947 WO2005009439A1 (en) 2003-07-17 2004-07-16 Muscarinic acetylcholine receptor antagonists

Publications (1)

Publication Number Publication Date
BRPI0412716A true BRPI0412716A (pt) 2006-09-26

Family

ID=34102735

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412716-1A BRPI0412716A (pt) 2003-07-17 2004-07-16 antagonistas de receptor muscarìnico de acetilcolina

Country Status (21)

Country Link
US (1) US20060178395A1 (pt)
EP (1) EP1648460A4 (pt)
JP (1) JP2007523877A (pt)
KR (1) KR20060063890A (pt)
CN (1) CN1822838A (pt)
AP (1) AP2006003478A0 (pt)
AR (1) AR045913A1 (pt)
AU (1) AU2004259232A1 (pt)
BR (1) BRPI0412716A (pt)
CA (1) CA2532375A1 (pt)
EA (1) EA200600267A1 (pt)
EC (1) ECSP056254A (pt)
IL (1) IL172822A0 (pt)
IS (1) IS8302A (pt)
MA (1) MA27900A1 (pt)
MX (1) MXPA06000662A (pt)
NO (1) NO20060775L (pt)
PE (1) PE20050327A1 (pt)
TW (1) TW200523261A (pt)
UY (1) UY28417A1 (pt)
WO (1) WO2005009439A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050250A1 (es) * 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonistas de los receptores muscarinicos de la acetilcolina
WO2005037280A1 (en) 2003-10-14 2005-04-28 Glaxo Group Limited Muscarinic acetycholine receptor antagonists
AU2004281167A1 (en) * 2003-10-17 2005-04-28 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists field of the invention
PE20050489A1 (es) * 2003-11-04 2005-09-02 Glaxo Group Ltd Antagonistas de receptores de acetilcolina muscarinicos
WO2005087236A1 (en) * 2004-03-11 2005-09-22 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
EP1725238A4 (en) * 2004-03-17 2009-04-01 Glaxo Group Ltd M 3 MUSCARINACETYLCHOLINE RECEPTOR ANTAGONISTS
JP2007529513A (ja) * 2004-03-17 2007-10-25 グラクソ　グループ　リミテッド Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
UY28871A1 (es) 2004-04-27 2005-11-30 Glaxo Group Ltd Antagonistas del receptor de acetilcolina muscarinico
EP1747219A4 (en) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptor
WO2006055553A2 (en) * 2004-11-15 2006-05-26 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
TWI268704B (en) * 2005-06-28 2006-12-11 Realtek Semiconductor Corp Apparatus and method for detecting vertical blanking interval
US20080234315A1 (en) * 2005-08-02 2008-09-25 Jakob Busch-Petersen M3 Muscarinic Acetylcholine Receptor Antagonists
PE20091553A1 (es) 2008-02-06 2009-10-30 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
UY31636A1 (es) 2008-02-06 2009-08-03 Farmacoforos duales-antagonistas muscarinicos de pde4
AR070562A1 (es) 2008-02-06 2010-04-21 Glaxo Group Ltd Farmacoforos duales - antagonistas muscarinicos de pde4
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
US20150093440A1 (en) * 2010-10-15 2015-04-02 Glaxo Group Limited Aggregate nanoparticulate medicament formulations, manufacture and use thereof
CN104470503A (zh) 2012-04-13 2015-03-25 葛兰素史克知识产权开发有限公司 聚集粒子
WO2021191875A1 (en) 2020-03-26 2021-09-30 Glaxosmithkline Intellectual Property Development Limited Cathepsin inhibitors for preventing or treating viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800481A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800482A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab Olefinic derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) * 1955-07-01 1957-07-23 Smith Kline French Lab 3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US6350758B1 (en) * 1996-12-02 2002-02-26 Georgetown University Tropane derivatives and method for their synthesis
US6248752B1 (en) * 1998-02-27 2001-06-19 Charles Duane Smith Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
NZ513575A (en) * 1999-05-04 2003-07-25 Neurosearch As Heteroaryl diazabicycloalkanes useful for treating or preventing a disease or a disorder responsive to the activity of nAChR modulators
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1302458A4 (en) * 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTERDERIVATE
CN1571787A (zh) * 2001-10-17 2005-01-26 Ucb公司 奎宁环衍生物、制备它们的方法和它们作为m2和/或m3毒蕈碱受体抑制剂的用途
ES2329586T3 (es) * 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.

Also Published As

Publication number Publication date
KR20060063890A (ko) 2006-06-12
MXPA06000662A (es) 2006-03-30
AU2004259232A1 (en) 2005-02-03
IS8302A (is) 2006-02-14
US20060178395A1 (en) 2006-08-10
WO2005009439A1 (en) 2005-02-03
CA2532375A1 (en) 2005-02-03
NO20060775L (no) 2006-04-11
JP2007523877A (ja) 2007-08-23
AP2006003478A0 (en) 2006-02-28
PE20050327A1 (es) 2005-06-08
UY28417A1 (es) 2005-02-28
EP1648460A4 (en) 2009-04-01
AR045913A1 (es) 2005-11-16
EP1648460A1 (en) 2006-04-26
CN1822838A (zh) 2006-08-23
EA200600267A1 (ru) 2006-06-30
TW200523261A (en) 2005-07-16
MA27900A1 (fr) 2006-05-02
ECSP056254A (es) 2006-04-19
IL172822A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
BRPI0415361A (pt) antagonistas do receptor muscarìnico de acetilcolina
BRPI0510170A (pt) antagonistas do receptor muscarìnico de acetilcolina
BRPI0412716A (pt) antagonistas de receptor muscarìnico de acetilcolina
UY28598A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
BRPI0412679A (pt) antagonistas de receptor muscarìnico de acetilcolina
BRPI0417343A (pt) antagonistas do receptor muscarìnico m3 de acetilcolina
UY27927A1 (es) Antagonistas del receptor muscarínico m3 de acetilcolina
BRPI0417215A (pt) antagonistas de receptor muscarìnico de acetilcolina m3
BRPI0412537A (pt) antagonista do receptor muscarìnico da acetilcolina
DE602005011593D1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
PT1237559E (pt) Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano
BRPI0415281A (pt) antagonistas de receptor de acetilcolina muscarìnico
UY28557A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
ITNA20030066A1 (it) Procedimento per il consolidamento e la protezione di materiali lapidei mediante l&#39;uso di copolimeri acrilici.
ITMI20030830A1 (it) Macchina e procedimento e per l&#39;analisi di documenti.
BR0002142A (pt) Inibidores de quinase myti

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.